Catherine Mela
Executive Director, Head Biomarker Operations GlaxoSmithKline
Seminars
Tuesday 31st March 2026
Panel Discussion: Advancing Sample Management & Pre-Analytic Workflows for Robust, Reproducible Clinical Outcomes
4:50 pm
- How can early integration of a global-ready sample and biomarker strategy into clinical design reduce downstream risk of sample or data variability?
- What are the key approaches to harmonizing pre-analytical workflows, and how can they be controlled across multi-site operations?
- What innovations in digital tools are facilitating end-to-end integrity and reproducibility?
- How are sponsors ensuring consistency in biospecimen handling when working across multiple CROs or laboratory partners?
- What level of collaboration between translational scientists, clinicians, and data teams is needed to ensure biomarker hypotheses remain viable throughout trial execution?
Tuesday 31st March 2026
Getting Laboratories Off the Critical Path
5:20 pm
- Thinking digital – how can we plan better and reduce handoffs of data and requirements
- How to keep track of the geopolitical changes in requirements
- Managing pre-analytics should not be left to chance!
